Suzhou Hepathera Biotech Co., Ltd.

This study is testing whether two new injections, HT-101 and HT-102, can help control chronic hepatitis B. It will involve 60 participants who already have the virus and are on standard medication. The main goal is to see if the combination can reduce or eliminate detectable sign…

This study is testing the safety and effects of two new injections, HT-101 and HT-102, in people with chronic hepatitis B. About 86 participants will receive the injections every four weeks for up to 48 weeks, while continuing their standard antiviral pills. The main goal is to s…